CytexOrtho
  • Home
  • Technology
  • News
  • Contact
  • About
    • Mission and Team
    • FAQ
    • Disclosures
  • For Patients
Select Page

Corporate and Scientific Integrity Policy

by CytexOrtho | May 20, 2024 | Disclosures

    COI Policy View...

SEC Filings

by CytexOrtho | May 1, 2023 | Disclosures

This is the 2024 Form C-AR as required by the SEC.   2024 Form C-AR View...

Recent Posts

  • MedTech Jam Session featuring CytexOrtho!
  • Behind the Booth with CytexOrtho
  • CytexOrtho at MedTech World
  • CEO Interview with SmartTRAK
  • 3DHEALS Interview with Dr. Brad Estes

Recent Comments

  1. Steve Scheftic on Breakthrough Device Designation from the FDA
  • Follow
  • Follow
  • Follow
  • Follow

Products are in development. This is potential future technology and not approved by the FDA and not commercially available. The innovations described above are all currently in development. Features and performances of future technologies may vary. Access to future technologies are contingent upon regulatory approval. Approval timelines are subject to the regulatory process of individual countries and regions and not guaranteed.

© 2026 Cytex Therapeutics, Inc now DBA CytexOrtho. All rights reserved